Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

AZ’s triple therapy inhaler hits 8 out of 9 endpoints

January 26, 2018
Medical Communications, Research and Development AstraZeneca, COPD, biotech, drugs, pharma, pharmaceutical

AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints …

News

Biogen announces acquisition along with financials, but it’s tiny

January 26, 2018
Medical Communications, Sales and Marketing Biogen, Karyopharm, biotech, drugs, pharma, pharmaceutical

Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …

News
aging_-_hand

Senescent cell findings provides Parkinson’s treatment clue

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …

News
old_man_bar

Amyloid pathway doubts after latest Alzheimer’s failure

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …

News
gw_pharma

GW Pharma boasts new positive data, readying for approval

January 25, 2018
Research and Development GW Pharma, biotech, drugs, pharma, pharmaceutical

The latest data from GW Pharma is about as conclusively positive as you can usually hope to get with a …

News
celgene_exteriors-3

Celgene confirms rumours, with $9bn deal for Juno

January 22, 2018
Manufacturing and Production, Sales and Marketing CAR-T, Celgene, biotech, drugs, juno therapeutics, pharma, pharmaceutical

It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on …

News
biogen_austria_238

Biogen’s Spinraza to go before NICE

January 22, 2018
Sales and Marketing Biogen, Spinraza, biotech, drugs, pharma, pharmaceutical

Biogen received marketing approval from the European Commission for Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA), in May …

News
facilities_lg06

Court fines Dr Reddy’s for improperly packaging products

January 22, 2018
Sales and Marketing Dr Reddy's, biotech, drugs, pharma, pharmaceutical

On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …

News
sanofi_new_paris_hq

Sanofi finally seals big deal with $11.6bn for Bioverativ

January 22, 2018
Sales and Marketing Sanofi, biotech, bioverativ, drugs, pharma, pharmaceutical

Sanofi interest in making a big acquisition has been clear for the last few years and its struggles to solidify …

News
sandoz

Novartis enters biosimilar agreement with Biocon

January 19, 2018
Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …

News
gilead-sciences

Gilead aims to claim edge with Pfizer CAR-T combo

January 18, 2018
Medical Communications, Research and Development Gilead, Kite, Yescarta, biotech, drugs, pharma, pharmaceutical

Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …

News
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …

Feature
darzalex

NICE meets Janssen halfway over Darzalex

January 18, 2018
Medical Communications, Sales and Marketing J&J, JJ, Janssen, biotech, darzalex, drugs, pharma, pharmaceutical

NICE rejected Janssen’s Darzalex (Daratumumab) back in March last year, concluding that it wasn’t able to accurately determine the efficacy …

News
blood-20745_960_720

Research calls for BRCA testing in all women

January 18, 2018
Medical Communications, Research and Development BRCA, biotech, drugs, pharma, pharmaceutical

For women, possessing a mutated BRCA1 or BRCA2 gene significantly increases the chances of developing breast or ovarian cancer; at …

News
cabometyx_tablets_60_mg_40_mg_20_mg

Ipsen ends P3 trial on liver cancer early due to strong data

January 18, 2018
Research and Development Cabometyx, Exelixis, biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025